Ingolf Schiefke

A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis

Stephen A. Harrison, Pierre Bédossa, Cynthia D. Guy et al. · New England Journal of Medicine · 2024 · 1.4K citations · Full text

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Zobair M. Younossi, Vlad Ratziu, Rohit Loomba et al. · The Lancet · 2019 · 1.2K citations · Full text

Interim Analysis, Metabolic Associated Steatohepatitis, Hepatology +7

Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue et al. · Journal of Hepatology · 2020 · 438 citations

Fibrosis, Hepatology, Liver Physiology +9

A Polymorphism Near IL28B Is Associated With Spontaneous Clearance of Acute Hepatitis C Virus and Jaundice

Hans L. Tillmann, A. Thompson, Keyur Patel et al. · Gastroenterology · 2010 · 319 citations

Il28b Is Associated, Autoimmune Disease, Hepatitis C +12

Use of Intestinal Ultrasound to Monitor Crohn’s Disease Activity

Torsten Kucharzik, Bianca M. Wittig, Ulf Helwig et al. · Clinical Gastroenterology and Hepatology · 2016 · 237 citations

Medical Ultrasound, Intestinal Ultrasound, Gastroenterology +4